12 Health Care Stocks Moving In Monday's Pre-Market Session

AIM ImmunoTech Inc. Common Stock AIM	0.00	0.00%
Artelo Biosciences Inc ARTL	0.00	0.00%
Citius Pharmaceuticals Inc CTXR	0.00	0.00%
Gossamer Bio GOSS	0.00	0.00%
GeoVax Labs, Inc. GOVX	0.00	0.00%

Gainers

Sunshine Biopharma (NASDAQ:SBFM) stock moved upwards by 635.6% to $2.09 during Monday's pre-market session. The company's market cap stands at $1.3 million. As per the news, the Q1 earnings report came out 3 days ago.
Geovax Labs (NASDAQ:GOVX) shares rose 169.91% to $3.32. The market value of their outstanding shares is at $4.2 million. The company's, Q1 earnings came out 2 days ago.
Virax Biolabs Group (NASDAQ:VRAX) shares increased by 100.71% to $0.31. The market value of their outstanding shares is at $1.1 million.
AIM ImmunoTech (AMEX:AIM) shares rose 45.73% to $0.37. The market value of their outstanding shares is at $3.9 million. The company's, Q1 earnings came out yesterday.
Quantum Cyber (NASDAQ:QUCY) shares moved upwards by 17.05% to $4.05. The company's market cap stands at $43.3 million.
Picard Medical (AMEX:PMI) stock increased by 16.74% to $0.19. The market value of their outstanding shares is at $14.7 million. As per the news, the Q1 earnings report came out yesterday.

Losers

WORK Medical Tech Gr (NASDAQ:WOK) shares fell 25.5% to $0.49 during Monday's pre-market session.
P3 Health Partners (NASDAQ:PIII) shares decreased by 22.53% to $8.75. The market value of their outstanding shares is at $37.5 million. As per the news, the Q1 earnings report came out 2 days ago.
Artelo Biosciences (NASDAQ:ARTL) shares decreased by 17.4% to $1.52. The company's market cap stands at $4.0 million. The company's, Q1 earnings came out 2 days ago.
Citius Pharmaceuticals (NASDAQ:CTXR) shares declined by 16.15% to $0.59. The market value of their outstanding shares is at $19.2 million. As per the press release, Q2 earnings came out yesterday.
Gossamer Bio (NASDAQ:GOSS) shares decreased by 14.71% to $0.29. The market value of their outstanding shares is at $79.7 million. As per the press release, Q1 earnings came out yesterday.
Lantern Pharma (NASDAQ:LTRN) stock fell 14.34% to $2.69. The company's market cap stands at $40.0 million. The company's, Q1 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.